Details of the Drug

General Information of Drug (ID: DMDNPAV)

Drug Name
TTI-621
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Phase 1 [1]
Melanoma 2C30 Phase 1 [2]
Merkel cell carcinoma 2C34 Phase 1 [2]
Mycosis fungoides 2B01 Phase 1 [2]
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Squamous cell carcinoma 2B60-2D01 Phase 1 [2]
⏷ Show the Full List of Indication(s)
Drug Type
Recombinant protein
Cross-matching ID
TTD ID
D01CUO
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukocyte surface antigen CD47 (CD47) TT28S46 CD47_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)